January 25, 2021
Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty
January 25, 2021
Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty
January 25, 2021
January 25, 2021
January 25, 2021
Fourth-quarter highlights
• Sales amounted to EUR 6.0 billion, with 7% comparable sales growth
• Comparable order intake increased 7%
• Income from continuing operations increased to …
SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today …
Read moreATLANTA, Jan. 22, 2021 (GLOBE NEWSWIRE) — Secureworks® (NASDAQ: SCWX), a software-driven security solutions leader, today …
Read moreNEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire — InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, today announces via an InvestorWire Global Release translated …
Read more